As the global battle against the COVID-19 pandemic rages on, new variants continue to emerge, each with its unique set of characteristics and challenges. Among these variants is JN.1, a strain that has raised alarms due to its association with an increased risk of pneumonia.
First identified through genomic surveillance, JN.1 shares similarities with other variants of concern, such as Delta and Omicron. However, its distinct genetic makeup has sparked concerns among public health experts, particularly regarding its impact on the respiratory system.
